A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL

~64 mi. (Lund, Sweden, +143 more cities)

Skånes Universitetssjukhus i Lund

del(17)(p10), +1 more biomarker

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

bendamustine, +3 more drugs

chemotherapy, +2 more types

A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer

~64 mi. (Lund, Sweden, +209 more cities)

Skanes University Hospital - Universitetssjukhus

ERBB2 Amplification, +1 more biomarker

Breast Carcinoma

ado-trastuzumab emtansine, +1 more drug

targeted therapy

Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis

~64 mi. (Lund, Sweden, +189 more cities)

Skane University Hospital Lund /ID# 220834

del(11)(q10), +27 more biomarkers

Myelofibrosis Transformation in Essential Thrombocythemia, +2 more conditions

navitoclax, +1 more drug

targeted therapy

Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

~64 mi. (Lund, Sweden, +177 more cities)

Skane University Hospital

BCR-ABL1 Fusion, +1 more biomarker

Acute Lymphoblastic Leukemia

allogeneic hematopoietic stem cell transplantation, +18 more drugs

cellular therapy, +4 more types

Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis

~64 mi. (Lund, Sweden, +165 more cities)

Skane University Hospital Lund /ID# 220835

del(11)(q10), +27 more biomarkers

Myelofibrosis

navitoclax, +1 more drug

targeted therapy

Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007)

~64 mi. (Lund, Sweden, +115 more cities)

Skanes Universitetssjukhus Lund. ( Site 2001)

ATM Loss, +27 more biomarkers

Breast Carcinoma, +2 more conditions

olaparib, +1 more drug

immunotherapy, +1 more type

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL) or Pancreatic Neuroendocrine Tumor (pNET) (MK-6482-015)

~64 mi. (Lund, Sweden, +29 more cities)

Skanes University Hospital Lund ( Site 1200)

Pancreatic Neuroendocrine Tumor, +1 more condition

belzutifan

targeted therapy

A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080)

~64 mi. (Lund, Sweden, +46 more cities)

Skanes Universitetssjukhus Lund. ( Site 0525)

Malignant Solid Tumor

lenvatinib

targeted therapy

Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)

~78 mi. (Malmö, Sweden, +199 more cities)

Skane University Hospital ( Site 0692)

Hepatocellular Carcinoma

pembrolizumab

immunotherapy

Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Cisplatin-ineligible Participants With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)

~94 mi. (København Ø, Denmark, +163 more cities)

Rigshospitalet University Hospital ( Site 0411)

Bladder Urothelial Carcinoma

cystectomy, +2 more drugs

chemotherapy, +3 more types

Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia

~94 mi. (København Ø, Denmark, +18 more cities)

Rigshospitalet

MS4A1 Expression

Chronic Lymphocytic Leukemia, +2 more conditions

epcoritamab

immunotherapy

Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)

~95 mi. (Copenhagen, Denmark, +176 more cities)

Rigshospitalet University Hospital ( Site 2515)

Endometrial Carcinoma, +1 more condition

chemotherapy, +2 more drugs

chemotherapy, +2 more types